Last spring, a rapid polymerase chain reaction (PCR) test for COVID-19 — developed by Northwestern University spinoff company Minute Molecular Diagnostics — received emergency use authorization (EUA) ...

Because of its high accuracy, laboratory-based polymerase chain reaction (PCR) testing is the gold standard for infectious disease diagnostics. However, PCR technology requires highly trained staff ...

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to US$1.8 million to biotechnology company, Visby Medical, to develop a portable rapid polymerase chain ...

Researchers in Singapore have developed a prototype breathalyzer that is claimed to be as effective as PCR testing in identifying people with COVID-19. The system is over 95 percent accurate at ...

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

Molecular tests are far superior to rapid antigen tests—and now you can get them for home use. Amanda Blum is a freelancer who writes about smart home technology, gardening, and food preservation.

COVID-19 tests generally fall into two categories: rapid antigen tests, and slower but more accurate polymerase chain reaction tests. The FDA granted emergency use authorization to a test that bucks ...

Polymerase chain reaction (PCR) and rapid (antigen) tests for COVID-19 both involve taking a swab. Results for a PCR test take longer, as it needs to go to a laboratory. It is more costly but tends to ...

A polymerase chain reaction (PCR) test detects genetic material from a pathogen or abnormal cell sample. Ways of collecting samples include a nasal swab, a saliva swab, or taking a sample of blood.

A new highly sensitive, easy-to-use test for COVID-19 that requires a single swab and 15 minutes has received emergency use authorization (EUA) status from the US Food and Drug Administration (FDA).